Search results
Regeneron (REGN), Sanofi's Dupixent Succeeds in 2nd COPD Study
Zacks via Yahoo Finance· 5 months agoRegeneron Pharmaceuticals, Inc. REGN and partner Sanofi SNY announced positive study data on the...
What Is Severe Asthma?
Health via Yahoo News· 3 weeks agoRealPeopleGroup / Getty Images Medically reviewed by Reza Samad, MD Severe asthma is the term used for asthma that is difficult to treat and control....
AstraZeneca's (AZN) Asthma Drug Tezepelumab Gets Nod in Europe
Zacks via Yahoo Finance· 2 years agoAstraZeneca's (AZN) Tezspire is the only biologic medicine approved in Europe to treat severe asthma...
AstraZeneca's (AZN) Fasenra Gets FDA Nod for Asthma in Kids
Zacks via Yahoo Finance· 2 weeks agoAstraZeneca AZN announced that the FDA has approved its marketed asthma drug, Fasenra...
‘A huge shock to the system’: Doctors warn about asthma inhaler switch coming in January
CNN via Yahoo News· 4 months agoStarting January 1, a drug that thousands of patients depend on to help them breathe will disappear...
Flovent Inhalers Discontinued—Here's What People With Asthma Should Know
Health via Yahoo News· 4 months agoAs of January 1, drug manufacturer GSK has discontinued its Flovent asthma inhaler, and is producing...
Flovent asthma inhalers pulled from shelves and replaced with generic Jan. 1
USA TODAY via Yahoo News· 4 months agoOne of the most widely-used asthma and breathing treatments for over 20 years is being taken off the...
How Is Asthma Diagnosed?
Health via Yahoo News· 11 months agoAsthma is a chronic lung disease characterized by inflammation and narrowing of the airways, causing symptoms like shortness of breath, wheezing,...
Pharma Stock Roundup: FDA and EMA Regulatory Updates for ABBV, LLY, SNY & MRK's Drugs
Zacks via Yahoo Finance· 7 months agoThis week, the European Commission granted marketing approval to AbbVie’s ABBV Tepkinly...
Sanofi (SNY) Dupixent Gets CHMP Nod to Eosinophilic Esophagitis
Zacks via Yahoo Finance· 1 year agoThe CHMP recommends approval of Sanofi (SNY) and partner Regeneron's Dupixent for the treatment of...